PAPER Pellegrini L, Albecka A, Mallery DL, Kellner MJ, Paul D, Carter AP, James LC, Lancaster MA
SEARCH RESULTS
19580 RESULTS
PAPER Jacob F, Pather SR, Huang WK, Zhang F, Wong SZ, Zhou H, Cubitt B, Fan W, Chen CZ, Xu M, Pradhan M, Zhang DY, Zheng W, Bang AG, Song H, Carlos de la Torre J, Ming GL
Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium.
Cell Stem Cell. 2020 Dec 3;27(6):937-950.e9. Epub 2020 Sep 21 PubMed: 33010822PAPER Zhang BZ, Chu H, Han S, Shuai H, Deng J, Hu YF, Gong HR, Lee AC, Zou Z, Yau T, Wu W, Hung IF, Chan JF, Yuen KY, Huang JD
SARS-CoV-2 infects human neural progenitor cells and brain organoids.
Cell Res. 2020 Oct;30(10):928-931. Epub 2020 Aug 4 PubMed: 32753756Proteostasis Consortium Seminars- Genetic Analysis of Late Onset Neurodegeneration Implicates a Failure of Damage Response
CONFERENCE 2021-02-10 00:00:00-2021-02-10 00:00:00 Online Meeting 10 February 2021 Organizers: The Proteostasis Consortium led by Richard Morimoto, Ph.D., Northwestern University Speaker: John Hardy, PhD, University College London Meeting time: 12 PM EST Zoom link: https://stanford.zoom.us/j/94026057431 V
ISTAART Journal Club Meet the Author
CONFERENCE 2021-02-04 00:00:00-2021-02-04 00:00:00 Online Meeting 04 February 2021 João Pedro Ferrari Souza will lead a conversation with Renaud La Joie and Gil Rabinovici about the paper, Prospective Longitudinal Atrophy in Alzheimer’s Disease Correlates with the Intensity and Topography of Baseline Tau-
ISTAART Webinar- Guide to AAIC 2021: Reviewing
CONFERENCE 2021-02-02 00:00:00-2021-02-02 00:00:00 Online Meeting 02 February 2021 A free webinar featuring a step-by-step guide to reviewing abstracts; an overview of logistics; and expert insight from Eric Siemers; theme lead for Drug Development, AAIC 2021 Scientific Program Committee. Time: 10 am EST
Philip Scheltens, Arno de Wilde on In Phase 2, Donanemab Curbs Cognitive Decline in Early Alzheimer’s
COMMENT We were pleasantly surprised by Lilly’s announcement of the positive Phase 2 results. Although we have to wait for the full disclosure of all the data, it seems from the press release that the design of the trial ticked all the boxes of a proper Phase 2 s
Marco Bucci
PAPER Brawek B, Skok M, Garaschuk O
Changing Functional Signatures of Microglia along the Axis of Brain Aging.
Int J Mol Sci. 2021 Jan 22;22(3) PubMed: 33499206PAPER Forns J, Layton JB, Bartsch J, Turner ME, Dempsey C, Anthony M, Ritchey ME, Demos G
Increased risk of falls and fractures in patients with psychosis and Parkinson disease.
PLoS One. 2021;16(1):e0246121. Epub 2021 Jan 27 PubMed: 33503061PAPER Fais M, Sanna G, Galioto M, Nguyen TT, Trần MU, Sini P, Carta F, Turrini F, Xiong Y, Dawson TM, Dawson VL, Crosio C, Iaccarino C
LRRK2 Modulates the Exocyst Complex Assembly by Interacting with Sec8.
Cells. 2021 Jan 20;10(2) PubMed: 33498474PAPER Dolatshahi M, Sabahi M, Aarabi MH
Correction to: Pathophysiological Clues to how the Emergent SARS-CoV-2 Can Potentially Increase the Susceptibility to Neurodegeneration.
Mol Neurobiol. 2021 May;58(5):2395. PubMed: 33502737PAPER Andersen MS, Bandres-Ciga S, Reynolds RH, Hardy J, Ryten M, Krohn L, Gan-Or Z, Holtman IR, Pihlstrøm L, International Parkinson's Disease Genomics Consortium
Heritability Enrichment Implicates Microglia in Parkinson's Disease Pathogenesis.
Ann Neurol. 2021 May;89(5):942-951. Epub 2021 Mar 4 PubMed: 33502028PAPER Johnson EB, Ziegler G, Penny W, Rees G, Tabrizi SJ, Scahill RI, Gregory S
Dynamics of Cortical Degeneration Over a Decade in Huntington's Disease.
Biol Psychiatry. 2021 Apr 15;89(8):807-816. Epub 2020 Nov 18 PubMed: 33500176PAPER Davies MP, Benitez R, Perez C, Jakupovic S, Welsby P, Rzepecka K, Alder J, Davidson C, Martinez A, Hayes JM
Structure-Based Design of Potent Selective Nanomolar Type-II Inhibitors of Glycogen Synthase Kinase-3β.
J Med Chem. 2021 Feb 11;64(3):1497-1509. Epub 2021 Jan 26 PubMed: 33499592Current Filters
- Date Range : Apr 2020 to Apr 2021 x